CIENCIASMEDICASNEWS: Using Rabbit Monoclonal Antibodies for Key Parkinson’s Disease Targets

viernes, 30 de noviembre de 2018

Using Rabbit Monoclonal Antibodies for Key Parkinson’s Disease Targets

	November 29, 2018
	Immunology
	The latest immunology news from News Medical

Using Rabbit MonoclonalAntibodies for Key Parkinson’s Disease Targets

Rabbit monoclonal antibodies are paving the way in the fight against Parkinson’s disease by accelerating research through targeting key Parkinson’s disease proteins. See Abcam's Custom Antibody Solutions to help scientists develop and produce antibodies that fuel their research.

			Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation A group of Massachusetts General Hospital investigators is proposing that targeting immune checkpoints - molecules that regulate the activity of the immune system - in immune cells called microglia could reduce the inflammatory aspects of important neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

			Computational model helps predict immune response in patients undergoing heart surgery A research team led by Peter Sloot, professor of Complex Adaptive Systems at the UvA, has managed to pinpoint the mechanisms behind the immune response triggered in patients undergoing open heart surgery.

	The immune system also plays a key role in day-to-day function of healthy organs The cells of the immune system sustain life by infiltrating infected and dmaged tissue and eliminating pathogenic microorganisms and cell debris.

	Researchers use mRNA-loaded carriers to target genetic instructions of protein in immune cells Delivering an effective therapeutic payload to specific target cells with few adverse effects is considered by many to be the holy grail of medical research. A new Tel Aviv University study explores a biological approach to directing nanocarriers loaded with protein "game changers" to specific cells.

	Study shows how machinery within immune system activates T cells to attack cancer In just a few years, CAR T-cell and other adoptive T-cell therapies have emerged as among the most promising forms of cancer immunotherapy.

	The Immune Checkpoint Pathway - PD-1 Recombinant Protein Collection One of the focuses for cancer research is the immune checkpoint pathway, and PD-1 is one of the better characterized checkpoint proteins.